1244 related articles for article (PubMed ID: 24892468)
1. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
[TBL] [Abstract][Full Text] [Related]
2. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
[TBL] [Abstract][Full Text] [Related]
3. Perioperative management of antithrombotic therapy in cardiovascular patients.
Nuttall MT; Rodgers GM
Methodist Debakey Cardiovasc J; 2011; 7(4):10-4. PubMed ID: 22143470
[TBL] [Abstract][Full Text] [Related]
4. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results.
Capuano C; Sesana M; Leonzi O; Cuccia C
J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):866-71. PubMed ID: 17122672
[TBL] [Abstract][Full Text] [Related]
6. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
7. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Douketis JD; Berger PB; Dunn AS; Jaffer AK; Spyropoulos AC; Becker RC; Ansell J
Chest; 2008 Jun; 133(6 Suppl):299S-339S. PubMed ID: 18574269
[TBL] [Abstract][Full Text] [Related]
8. [Anticoagulation and antiplatelet therapy, and gastrointestinal endoscopy].
Székely H; Tulassay Z
Orv Hetil; 2009 Mar; 150(12):541-8. PubMed ID: 19275971
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic and anticoagulant therapy for atrial fibrillation.
Dzeshka MS; Lip GY
Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
[TBL] [Abstract][Full Text] [Related]
10. Bridging of oral anticoagulation therapy for invasive procedures.
Spyropoulos AC
Curr Hematol Rep; 2005 Sep; 4(5):405-13. PubMed ID: 16131443
[TBL] [Abstract][Full Text] [Related]
11. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention.
Scharf RE
Hamostaseologie; 2009 Nov; 29(4):388-98. PubMed ID: 19882082
[TBL] [Abstract][Full Text] [Related]
12. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
13. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
[TBL] [Abstract][Full Text] [Related]
14. Peri-operative management of anticoagulation and antiplatelet therapy in gastrointestinal surgery.
Degirmenci SE; Steib A
J Visc Surg; 2014 Apr; 151(2):125-35. PubMed ID: 24631468
[TBL] [Abstract][Full Text] [Related]
15. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
May AE; Geisler T; Gawaz M
Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting.
Lacoste JL; Hansen CL
Am J Health Syst Pharm; 2019 Sep; 76(18):1395-1402. PubMed ID: 31505555
[TBL] [Abstract][Full Text] [Related]
17. Periprocedural management of oral anticoagulation in patients with atrial fibrillation: approach in the era of new oral anticoagulants.
Healey JS; Brambatti M
Can J Cardiol; 2013 Jul; 29(7 Suppl):S54-9. PubMed ID: 23790599
[TBL] [Abstract][Full Text] [Related]
18. [Managing antithrombotic therapy in vitreoretinal surgery].
Gallice M; Rouberol F; Albaladejo P; Brillat Zaratzian E; Palombi K; Aptel F; Romanet JP; Chiquet C
J Fr Ophtalmol; 2015 Jan; 38(1):61-73. PubMed ID: 25577431
[TBL] [Abstract][Full Text] [Related]
19. Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy.
Ramirez A; Wall TS; Schmidt M; Selzman K; Daccarett M
Expert Rev Cardiovasc Ther; 2011 May; 9(5):609-14. PubMed ID: 21615324
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
